Related Experiment Videos
Antiplatelet therapy
1Department of Cardiology, Glenfield Hospital NHS Trust, Leicester.
Hospital Medicine (London, England : 1998)
|March 29, 2000
Abstract:
Within the last few years antiplatelet therapy has developed exponentially, with new agents being tested in an increasing number of clinical scenarios. The mechanism of action of these newer agents and evidence of benefit is prevented in this review.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical outcomes of patients discharged from the Rapid Access Chest Pain Clinic with non-anginal chest pain: A retrospective cohort study.
International journal of cardiology·2019
Clinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo.
Alimentary pharmacology & therapeutics·2010
Contemporary percutaneous coronary intervention--30 years in the making.
Clinical medicine (London, England)·2008
Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
Heart (British Cardiac Society)·2005
Drug eluting stents in interventional cardiology -- current evidence and emerging uses.
Current drug targets. Cardiovascular & haematological disorders·2005
Bisphosphonates' use in metastatic bone disease.
Hospital medicine (London, England : 1998)·2005
What do specialist registrars know about clinical governance?
Hospital medicine (London, England : 1998)·2005
Management of craniofacial abnormalities.
Hospital medicine (London, England : 1998)·2005
Osteoporosis and hypogonadism in men.
Hospital medicine (London, England : 1998)·2005
Time to hand over our old way of working?
Hospital medicine (London, England : 1998)·2005
Pelvic fractures and high energy traumas.
Hospital medicine (London, England : 1998)·2005
From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development.
Clinical pharmacology and therapeutics·2026
From prediction to performance: In silico-supported formulation of amorphous solid dispersions for PROTAC NX-2127.
International journal of pharmaceutics: X·2026
Five-Year Clinical Outcomes of Biodegradable Versus Durable Polymer Drug-Eluting Stents: A Propensity Score-Matched Analysis of 4394 Patients.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026